| Literature DB >> 29967663 |
Vivian F Silva Kahl1, Varinderpal Dhillon2, Michael Fenech2, Melissa Rosa de Souza1, Fabiane Nitzke da Silva1, Norma Anair Possa Marroni3,4, Emilene Arusievicz Nunes5, Giselle Cerchiaro5, Tatiana Pedron6, Bruno Lemos Batista6, Mónica Cappetta7, Wilner Mártinez-López8, Daniel Simon9, Juliana da Silva1.
Abstract
Pesticides used at tobacco fields are associated with genomic instability, which is proposed to be sensitive to nutritional intake and may also induce epigenetic changes. We evaluated the effect of dietary intake and genetic susceptibility polymorphisms in MTHFR (rs1801133) and TERT (rs2736100) genes on genomic and epigenetic instability in tobacco farmers. Farmers, when compared to a nonexposed group, showed increased levels of different parameters of DNA damage (micronuclei, nucleoplasmic bridges, and nuclear buds), evaluated by cytokinesis-block micronucleus cytome assay. Telomere length (TL) measured by quantitative PCR was shorter in exposed individuals. Global DNA methylation was significantly decreased in tobacco farmers. The exposed group had lower dietary intake of fiber, but an increase in cholesterol; vitamins such as B6, B12, and C; β-carotene; and α-retinol. Several trace and ultratrace elements were found higher in farmers than in nonfarmers. The MTHFR CT/TT genotype influenced nucleoplasmic bridges, nuclear buds, and TL in the exposed group, whereas TERT GT/TT only affected micronucleus frequency. We observed a positive correlation of TL and lipids and an inverse correlation of TL and fibers. The present data suggest an important role of dietary intake and subjects' genetic susceptibility to xenobiotics-induced damages and epigenetic alterations in tobacco farmers occupationally exposed to mixtures of pesticides.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29967663 PMCID: PMC6009020 DOI: 10.1155/2018/7017423
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Population descriptive, including nutritional intake data (based on individuals' reminder intake) and vitamin B12 serum level.
| Parameters | Nonexposed ( | Exposed ( |
|
|---|---|---|---|
| Gender ( | |||
| Male | 19 (47.5) | 19 (47.5) | >0.999b |
| Female | 21 (52.5) | 21 (52.5) | |
| Age (mean ± SE) | 45.6 ± 1.7 | 45.0 ± 1.8 | 0.797 |
| Male | 45.3 ± 2.6 | 44.5 ± 2.7 | 0.824 |
| Female | 45.8 ± 2.4 | 45.4 ± 2.5 | 0.891 |
| | 0.8907 | 0.8173 | |
| Years of work in tobacco fields (mean ± SE) | — | 28.3 ± 2.1 | |
| Male | 0 | 29.8 ± 3.2 | |
| Female | 0 | 26.8 ± 2.8 | |
| | — | 0.4919 | |
| Body mass index (BMI) | 27.8 ± 0.8 | 27.6 ± 0.9 | 0.844 |
| Male | 27.2 ± 0.8 | 25.5 ± 0.8 | 0.120 |
| Female | 27.1 ± 1.0 | 28.4 ± 1.2 | 0.439 |
| | 0.9360 | 0.1000 | |
| Dietary intake | |||
| Lipids (%)d | 31.8 ± 1.2 | 30.4 ± 0.8 | 0.333 |
| Cholesterol (mg) | 247.1 ± 20.5 | 339.1 ± 22.0 |
|
| Fibers (g) | 26.5 ± 1.0 | 24.8 ± 1.4 | 0.312 |
| Vitamin B6 (mg) | 1.86 ± 0.07 | 2.24 ± 0.11 |
|
| Folate ( | 177.5 ± 15.3 | 180.3 ± 13.0 | 0.890 |
| Vitamin C (mg) | 91.5 ± 11.3 | 124.2 ± 10.7 |
|
| Vitamin E (mg) | 34.8 ± 2.2 | 36.4 ± 2.8 | 0.666 |
| B-carotene (mg) | 474.2 ± 56.2 | 724.5 ± 66.1 |
|
| A-retinol ( | 556.8 ± 52.5 | 473.7 ± 34.3 | 0.362 |
| Vitamin B12 (pg/mL) | 400.6 ± 18.2 | 564.0 ± 33.7 |
|
a p value between nonexposed and exposed groups; bFischer's exact test; cp value between male and female individuals within each group; don a daily 2000 calorie diet. SE: standard error.
CBMN parameters, telomere length (bp), and global DNA methylation (%) results for nonexposed and exposed groups. Data presented as mean ± standard error (SE).
| Parameters | Nonexposed ( | Exposed ( |
|
|---|---|---|---|
|
| |||
| Micronucleusa | 2.9 ± 0.4 | 6.0 ± 0.5 |
|
| Nucleoplasmic bridgea | 2.6 ± 0.4 | 6.0 ± 0.5 |
|
| Nuclear budsa | 2.0 ± 0.4 | 4.0 ± 0.4 |
|
| Binucleated cellsb | 61.3 ± 8.2 | 120.6 ± 8.4 |
|
| Apoptosisb | 3.4 ± 0.4 | 3.9 ± 0.6 | 0.479 |
| Necrosisb | 3.6 ± 0.6 | 3.7 ± 0.8 | 0.978 |
|
| 4551 ± 145.5 | 4098 ± 105.3 |
|
|
| 3.804 ± 0.206 | 3.023 ± 0.131 |
|
aFrequency per 1000 BN cells; bfrequency per 500 cells; cp value between nonexposed and exposed groups; unpaired t-tests.
Concentration of trace (μg/mL) and ultratrace elements (ng/mL) determined in whole blood for both nonexposed and exposed groups. Data presented as mean ± standard error (SE). Unpaired t-test.
| Element | Nonexposed ( | Exposed ( |
|
|---|---|---|---|
| Aluminium (Al) | 112.60 ± 12.00 | 230.50 ± 37.10 |
|
| Antimony (Sb) | 16.15 ± 2.64 | 19.17 ± 3.27 | 0.474 |
| Arsenic (As) | 3.61 ± 0.70 | 7.88 ± 1.27 |
|
| Barium (Ba) | 25.37 ± 3.30 | 19.62 ± 2.08 | 0.310 |
| Beryllium (Be) | 0.11 ± 0.01 | 0.09 ± 0.01 | 0.548 |
| Bismuth (Bi) | 0.83 ± 0.09 | 0.67 ± 0.09 | 0.211 |
| Cadmium (Cd) | 0.83 ± 0.07 | 0.99 ± 0.08 | 0.169 |
| Calcium (Ca) | 312,752 ± 34,868 | 271,559 ± 36,957 | 0.420 |
| Chromium (Cr) | 5.08 ± 0.66 | 8.44 ± 1.30 |
|
| Cobalt (Co) | 0.48 ± 0.06 | 0.59 ± 0.07 | 0.261 |
| Copper (Cu) | 3322 ± 267.60 | 4785 ± 380.90 |
|
| Iron (Fe)a | 2,580,203 ± 109,596 | 2,657,316 ± 110,552 | 0.622 |
| Lead (Pb) | 73.49 ± 8.48 | 97.88 ± 12.42 | 0.181 |
| Lithium (Li) | 0.17 ± 0.79 | 0.96 ± 0.90 | 0.513 |
| Magnesium (Mg)a | 158,025 ± 4678 | 149,515 ± 3298 | 0.145 |
| Manganese (Mn) | 74.92 ± 4.33 | 71.08 ± 2.71 | 0.651 |
| Mercury (Hg) | 2.74 ± 0.45 | 1.80 ± 0.22 | 0.251 |
| Molybdenum (Mo) | 1.95 ± 0.30 | 2.41 ± 0.28 | 0.269 |
| Nickel (Ni) | 2.75 ± 0.50 | 5.90 ± 0.85 |
|
| Potassium (K)a | 6,380,585 ± 728,826 | 8,300,853 ± 284,196 |
|
| Selenium (Se) | 762.50 ± 37.21 | 640.50 ± 23.27 |
|
| Silver (Ag) | 0.54 ± 0.07 | 0.47 ± 0.09 | 0.514 |
| Sodium (Na)a | 6,232,252 ± 737,640 | 5,730,624 ± 795,854 | 0.645 |
| Vanadium (V) | 20.48 ± 1.65 | 19.76 ± 1.63 | 0.758 |
| Zinc (Zn)a | 24,793 ± 1396 | 29,155 ± 970.60 |
|
aTrace elements.
Genotype frequency distribution and allelic frequencies of MTHFR (rs1801133) and TERT (rs2736100) polymorphisms for nonexposed and exposed groups.
| Genotype | Nonexposed ( | Exposed ( |
|---|---|---|
| MTHFR | ||
| CC | 17 | 10 |
| CT | 21 | 15 |
| TT | 2 | 13 |
| Allelic frequencies | ||
| C | 0.69 | 0.46 |
| T | 0.31 | 0.54 |
| TERT | ||
| GG | 12 | 7 |
| GT | 16 | 19 |
| TT | 12 | 13 |
| Allelic frequencies | ||
| G | 0.50 | 0.42 |
| T | 0.50 | 0.58 |
Micronucleus (MN), nucleoplasmic bridge (NPB), nuclear buds (NBUD), and binucleated (BN) cell frequencies, telomere length (bp), and % of global DNA methylation for nonexposed and exposed groups according to MTHFR and TERT polymorphisms. Data presented as mean ± standard error (SE).
| Parameters |
|
|
|
| ||
|---|---|---|---|---|---|---|
| CC ( | CT/TT ( | GG ( | GT/TT ( | |||
|
| ||||||
| Micronucleusc | ||||||
| Nonexposed | 3.2 ± 0.7 (16) | 2.6 ± 0.4 (23) | 0.427 | 2.6 ± 0.5 (11) | 2.9 ± 0.5 (28) | 0.766 |
| Exposed | 5.0 ± 0.8 (10) | 6.2 ± 0.6 (28) | 0.307 | 7.6 ± 1.4 (7) | 4.9 ± 0.5 (32) |
|
| Nucleoplasmic bridgec | ||||||
| Nonexposed | 2.2 ± 0.4 (17) | 2.7 ± 0.7 (23) | 0.555 | 2.2 ± 0.6 (11) | 2.7 ± 0.5 (28) | 0.589 |
| Exposed | 6.6 ± 0.7 (10) | 4.7 ± 0.5 (28) |
| 5.0 ± 1.0 (7) | 5.5 ± 0.5 (32) | 0.641 |
| NBUDc | ||||||
| Nonexposed | 1.5 ± 0.4 (17) | 2.2 ± 0.5 (23) | 0.439 | 2.0 ± 0.5 (11) | 2.0 ± 0.6 (28) | 0.937 |
| Exposed | 4.7 ± 0.4 (10) | 3.0 ± 0.3 (28) |
| 3.6 ± 0.6 (7) | 3.1 ± 0.3 (32) | 0.535 |
| Binucleated cellsd | ||||||
| Nonexposed | 56.3 ± 7.0 (17) | 38.1 ± 3.9 (20) |
| 49.5 ± 7.1 (12) | 44.9 ± 4.9 (28) | 0.616 |
| Exposed | 106.7 ± 18.6 (10) | 121.8 ± 9.6 (28) | 0.441 | 135.3 ± 15.0 (7) | 115.1 ± 9.7 (31) | 0.359 |
| Telomere length | ||||||
| Nonexposed | 4266 ± 150.7 (16) | 5497 ± 468.4 (23) | 0.053 | 5824 ± 713.9 (11) | 4392 ± 125.1 (28) |
|
| Exposed | 3918 ± 206.9 (10) | 4406 ± 200.3 (28) | 0.164 | 4504 ± 765.9 (7) | 4161 ± 122.4 (31) | 0.656 |
| Global DNA methylation | ||||||
| Nonexposed | 3.779 ± 0.34 (16) | 3.821 ± 0.26 (23) | 0.922 | 3.659 ± 0.32 (10) | 3.862 ± 0.26 (25) | 0.662 |
| Exposed | 2.784 ± 0.24 (10) | 3.335 ± 0.14 (28) |
| 2.596 ± 0.26 (5) | 3.075 ± 0.12 (30) | 0.161 |
a p value between the CC genotype and the combination CT/TT within groups; bp value between the GG genotype and the combination GT/TT within groups; cevaluated in 1000 BN cells per individual; devaluated in 500 cells per individual.